Design and Synthesis of 4-Substituted
Benzamides as Potent, Selective, and
Orally Bioavailable IKs Blockers

Lloyd, John; Schmidt, Joan B.; Rovnyak, George; Ahmad, Saleem; Atwal, Karnail S.; Bisaha, Sharon N.; Doweyko, Lidia M.; Stein, Philip D.; Traeger, Sarah C.; Mathur, Arvind; Conder, Mary Lee; DiMarco, John; Harper, Timothy W.; Jenkins-West, Tonya; Levesque, Paul C.; Normandin, Diane E.; Russell, Anita D.; Serafino, Randolph P.; Smith, Mark A.; Lodge, Nicholas J.

doi:10.1021/jm015505u.s002

Design and Synthesis of 4-Substituted Benzamides as Potent, Selective, and Orally Bioavailable IKs Blockers

https://doi.org/10.1021/jm015505u.s002
Open external identifier URL

journal contribution

posted on 2001-10-17, 00:00 authored by John Lloyd, Joan B. Schmidt, George Rovnyak, Saleem Ahmad, Karnail S. Atwal, Sharon N. Bisaha, Lidia M. Doweyko, Philip D. Stein, Sarah C. Traeger, Arvind Mathur, Mary Lee Conder, John DiMarco, Timothy W. Harper, Tonya Jenkins-West, Paul C. Levesque, Diane E. Normandin, Anita D. Russell, Randolph P. Serafino, Mark A. Smith, Nicholas J. Lodge

Multiple delayed rectifier potassium currents, including IKs, are responsible for the repolarization and termination of the cardiac action potential, and blockers of these currents may be useful as antiarrhythmic agents. Modification of compound 5 produced 19(S) that is the most potent IKs blocker reported to date with >5000-fold selectivity over other cardiac ion channels. Further modification produced 24A with 23% oral bioavailability.

History

Related Materials

1.
DOI - Is supplement to Design and Synthesis of 4-Substituted Benzamides as Potent, Selective, and Orally Bioavailable IKs Blockers

Design and Synthesis of 4-Substituted Benzamides as Potent, Selective, and Orally Bioavailable <i>I</i><sub>Ks</sub> Blockers

History

Related Materials

Usage metrics

Categories

Keywords

Licence

Exports